The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Nov 2020 07:00

RNS Number : 7045G
Tungsten Corporation PLC
27 November 2020
 

Embargoed Release: 07:00hrs Friday 27 November 2020

 

 

 

TUNGSTEN CORPORATION PLC

 

("Tungsten" or the "Company")

 

TRADING UPDATE

 

Tungsten Corporation plc (AIM: TUNG), a leading provider of digital financial management products and software solutions, provides an update on current trading ahead of its interim results release on 14 December 2020.

 

As stated on 7 September 2020 in the Company's Full Year Results, Tungsten experienced challenging market conditions due to COVID-19 in Q1 FY21, resulting in a transaction volume decline of 8%. The announcement also stated that if transaction volumes remained at a similar percentage decline to that of Q1 levels for the remainder of FY21, revenues and adjusted EBITDA would be impacted. This trend has continued into Q2 FY21 resulting in a transaction volume decline of approximately 7% in H1 FY21. The current expectation is that transaction volumes will remain at lower levels for the remainder of FY21.

 

In H1 FY21 new business momentum has been positive with Tungsten securing 4 new customer wins however the Company is experiencing a longer sales conversion cycle which is conservatively expected to continue for the remainder of the current financial year. As a consequence of the transaction volumes in H1 FY21 and the continued expectation of lower transaction volumes in H2 FY21, together with a longer sales conversion cycle, the Company expects FY21 revenues to be similar to FY20. We expect to announce in the forthcoming interim results revenues of £18.0m excluding TNF.

 

Underlying adjusted EBITDA is now expected to be not less than £3.2m, materially lower than previous guidance. Adjusted EBITDA has been impacted by the lower transaction volumes, product mix of new sales, our new Total AR contracts requiring increased set-up costs, as well as additional costs related to our investment in the sales team. Planned actions were brought forward during H1 FY21 to reduce the Group's cost base, which will help improve the Group's underlying profitability going forward. The actions taken have had a short-term negative impact on cash in H1 FY21 but are expected to deliver annualised savings from FY22 of circa £4m.

 

As a result of the reduced revenue and adjusted EBITDA the Company's net cash balance at the end of FY21 is anticipated to be similar to the balance as at 31 October 2020 of £1m. This represents cash of £3m less £2m drawn on the RCF. As of today, £2m remains undrawn on the facility which expires in December 2024. This balance includes the impact of current year exceptional costs as well as the cash costs of prior year restructuring activities.

 

As part of the interim results preparation the Company shall also be reassessing the carrying value of goodwill for any impairment as a result of its revised guidance.

 

The Company expects the macro economic environment to remain challenging over the coming months but it does anticipate that, with the gradual easing of COVID-19 restrictions, transaction volumes will begin to return to pre-COVID levels during FY22.

 

Andrew Lemonofides, Tungsten's Chief Executive, commented:

 

"Tungsten has faced a difficult and unpredictable market in 2020. In spite of these challenges and the decline in transaction volumes, we have won new customer relationships and we expect to deliver broadly similar revenues to FY20. This performance is underpinned by the investments that we have continued to make in our sales and product capabilities, coupled with our operational gearing following our cost base reductions in H1.

 

It is disappointing that our profitability is going to be materially lower that we expected this year, however the Company remains focused on improving efficiency and converting its pipeline of opportunities to drive growth in sales."

 

 

 

Enquiries

Tungsten Corporation plc

Andrew Lemonofides, Chief Executive Officer

Ian Kelly, Interim Chief Financial Officer

 

 

+44 20 7280 6980

 

 

Canaccord Genuity Ltd (Nominated Advisor & Broker)

Simon Bridges

Andrew Potts

 

 

+44 20 7523 8000

 

 

Tavistock Communications Financial PR & IR

Heather Armstrong

Jos Simson

Katie Hopkins

 

+44 20 7920 3150

 

About Tungsten Corporation plc

 

Tungsten Corporation (AIM: TUNG) is the world's largest, compliant business transaction network. A leading global electronic invoicing and purchase order transactions network, Tungsten's mission is centred on enabling a touchless invoice process allowing businesses around the globe to gain maximum value from their invoice process.

 

Tungsten processes invoices for 74% of the FTSE 100 and 71% of the Fortune 500. It enables suppliers to submit tax compliant e-invoices in 50 countries, and last year processed transactions worth £195bn for organisations such as Caesars Entertainment, Computacenter, GlaxoSmithKline, Kraft Foods, Mohawk Industries, Mondelēz International, Procter & Gamble, Shaw Industries, Unilever and the US Federal Government.

 

Founded in 2000 and headquartered in London, Tungsten has offices in the US, Bulgaria and Malaysia, employing over 300 people.

 

Forward looking statements

This document contains forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. Any forward-looking statement is based on information available to Tungsten as of the date of this statement. All written or oral forward-looking statements attributable to Tungsten are qualified by this caution. Tungsten does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Tungsten's expectations.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBORRROUAURA
Date   Source Headline
2nd Jan 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jan 20204:35 pmRNSPrice Monitoring Extension
31st Dec 201912:40 pmRNSSecond Price Monitoring Extn
31st Dec 201912:35 pmRNSPrice Monitoring Extension
12th Dec 20197:00 amRNSInterim Results for six months to 31 October 2019
12th Dec 20197:00 amRNSPartnership with Orbian Corporation
9th Dec 20194:40 pmRNSSecond Price Monitoring Extn
9th Dec 20194:35 pmRNSPrice Monitoring Extension
29th Nov 201912:12 pmRNSHolding(s) in Company
9th Oct 20197:00 amRNSDirector/PDMR Share Dealing
20th Sep 20194:49 pmRNSDirector/PDMR Shareholding
19th Sep 20192:55 pmRNSResult of AGM
19th Sep 20197:00 amRNSTrading Update
1st Aug 20197:00 amRNSGrant of Options
25th Jul 20192:30 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSFinal Results for the year ended 30 April 2019
4th Jul 201912:07 pmRNSSecond Price Monitoring Extn
4th Jul 201912:02 pmRNSPrice Monitoring Extension
3rd Jul 20197:00 amRNSNew Chief Executive Officer
23rd May 20197:00 amRNSTrading Update
30th Apr 20197:00 amRNSInitial Results of the Operating Review
15th Apr 20197:00 amRNSDirector/PDMR Shareholding
1st Mar 201912:10 pmRNSDirector / PDMR Dealing
27th Feb 20199:29 amRNSDirector / PDMR Dealing
25th Feb 20191:45 pmRNS2019 Financial Calendar
25th Feb 20197:00 amRNSQ3 Trading Update
14th Feb 20194:40 pmRNSSecond Price Monitoring Extn
14th Feb 20194:35 pmRNSPrice Monitoring Extension
14th Feb 201912:07 pmRNSSecond Price Monitoring Extn
14th Feb 201912:02 pmRNSPrice Monitoring Extension
14th Feb 20197:00 amRNSDirectorate Change
11th Feb 20197:00 amRNSBoard Appointment
13th Dec 20187:01 amRNSDirectorate Change
13th Dec 20187:00 amRNSInterim Results for six months to 31 October 2018
4th Dec 201811:30 amRNSNotice of Interim 2019 Results
16th Nov 20184:41 pmRNSSecond Price Monitoring Extn
16th Nov 20184:35 pmRNSPrice Monitoring Extension
16th Nov 20189:30 amRNSTungsten Network secures SdI registration in Italy
13th Nov 20189:30 amRNSTungsten Network appoints new SVP global sales
9th Oct 20187:00 amRNSDirectorate Change
21st Sep 20183:50 pmRNSResult of AGM / Appointment of Deputy Chairman
21st Sep 20187:00 amRNSAGM Statement / Trading Update
17th Sep 20189:30 amRNSGroupM UK joins Tungsten Network
28th Aug 20185:33 pmRNSReplacement: Mailing of Notice of AGM & Proxy Form
28th Aug 20184:59 pmRNSMailing of Notice of AGM and Proxy Form
23rd Aug 20187:00 amRNSBoard Appointments
22nd Aug 201812:40 pmRNSHolding(s) in Company
13th Aug 20187:00 amRNSMailing of Annual Report
10th Aug 20182:44 pmRNSHolding(s) in Company - DCIL
7th Aug 20182:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.